✦ LIBER ✦

DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage

✍ Scribed by Ian M. Smith; Wojciech K. Mydlarz; Suhail K. Mithani; Joseph A. Califano

Publisher: John Wiley and Sons
Year: 2007
Tongue: French
Weight: 103 KB
Volume: 121
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.22889

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Epigenetic changes have been implicated in the pathogenesis of solid tumors, including head and neck squamous cell carcinoma (HNSCC). Prior efforts have primarily examined regional promoter hypermethylation as a silencer of tumor suppressor gene expression. To analyze the global state of methylation in the HNSCC genome, we utilize pyrosequencing of repetitive elements (LINEs) to compare the state of global methylation in HNSCC to normal aerodigestive mucosa. 137 samples (119 HNSCC tumors and 18 normal mucosal tissues) were digested to extract DNA and subjected to bisulfite treatment. Treated DNA was amplified using PCR primers for the repetitive LINEs sequence and produced a heterogeneous sample of products, from many genomic loci. These products were pyrosequenced to quantitatively evaluate their global genomic methylation status. HNSCC specimens showed global hypomethylation, with a mean level of genomic methylation of 46.8% methylated with a standard deviation of 9.0. Conversely, the normal upper airway mucosa had a global methylation level of 54.0 and a standard deviation of 4.6 (Mann–Whitney p value < 0.001). The tumor specimens also showed an increasing degree of hypomethylation associated with advanced tumor stage (ANOVA p‐value of 0.003). About 67% of HNSCC's are globally hypomethylated when evaluated against the minimum level of methylation in the normal mucosal specimens. Degree of global hypomethylation was associated with smoking history, alcohol use and stage in univariate analysis (p‐value 0.02), however, only HNSCC diagnosis remained significant on multivariate analysis. Despite the presence of regional promoter hypermethylation, HNSCC demonstrates global genomic hypomethylation. The effects of stage, alcohol use and smoking on global hypomethylation were not independently significant. © 2007 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Esophageal squamous cell cancer in patie

Esophageal squamous cell cancer in patients with head and neck cancer: Prevalence of human papillomavirus DNA sequences

✍ Ethel-Michele de Villiers; Karin Gunst; Harald Stein; Hans Scherübl 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 75 KB 👁 2 views

## Abstract An etiologic role for human papillomavirus (HPV) infections in either head and neck (HNC) or esophageal carcinogenesis remains debatable. Patients with head and neck cancer are at high risk for developing a second esophageal squamous cell cancer (ESCC). The aim of our study was to deter

Epigenetic inactivation of the SFRP gene

Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma

✍ Carmen J. Marsit; Michael D. McClean; Constance Sloane Furniss; Karl T. Kelsey 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 111 KB 👁 2 views

## Abstract The soluble frizzled receptor protein (__SFRP__) family encodes antagonists of the WNT pathway, and silencing of these genes, through promoter hypermethylation, leads to constitutive WNT signaling. In bladder cancers, hypermethylation of the __SFRP__ genes occurs more often in current a

Management of the neck in a randomized t

Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer

✍ Pierre Lavertu; David J. Adelstein; Jerrold P. Saxton; Michelle Secic; John R. W 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

Background. Treating the neck after organpreservation treatment with radiotherapy or chemoradiotherapy can be problematic. Methods. To develop management guidelines, we reviewed the results of a 100-patient phase-3 trial that had compared outcome after radiotherapy alone with outcome after chemorad

Human papillomavirus (HPV) in head and n

Human papillomavirus (HPV) in head and neck cancer : An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring

✍ I. Benjamin Paz; Nathan Cook; Tamara Odom-Maryon; Yuan Xie; Sharon P. Wilczynski 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 2 views

tissue examined. This study was undertaken to estimate the frequency of HPV DNA in squamous cell carcinoma (SCC) at different sites of the esophagus, head and neck and

A phase III randomized trial comparing c

A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results

✍ David J. Adelstein; Jerrold P. Saxton; Pierre Lavertu; Laurie Tuason; Benjamin G 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

Background. A phase III randomized comparison of radiotherapy alone versus combination chemotherapy and concurrent continuous-course radiotherapy was performed at the Cleveland Clinic Foundation. Methods. Between March 1990 and June 1995, 100 patients with resectable stage III and IV squamous cell

Prediction of treatment outcome by cispl

Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT)

✍ Frank J.P. Hoebers; Dick Pluim; Marcel Verheij; Alfons J.M. Balm; Harry Bartelin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 188 KB 👁 1 views

## Abstract The purpose of our study was to test the predictive value of cisplatin‐DNA adduct levels in head and neck squamous cell carcinoma (HNSCC) patients treated with cisplatin‐radiation. Patients with advanced‐stage HNSCC were treated within a randomized trial, investigating the optimal route